Evidence map›Paper›PMID 15987342›Full record

ArticleParasite immunology2005

Schistosoma infection inhibits cellular immune responses to core HCV peptides.

A Farid, M Al-Sherbiny, A Osman, N Mohamed, A Saad, M T Shata, D-H Lee, A M Prince, G T Strickland

Abstract read
In one paragraph

Article in Parasite immunology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Human schistosomiasis: clinical perspective: review.Journal of advanced research · 2013
    Review
  13. Hepatic and intestinal schistosomiasis: review.Journal of advanced research · 2013
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

A FaridEgyptian Reference Diagnostic Center, Dokki, Giza, Egypt.
M Al-Sherbiny
A Osman
N Mohamed
A Saad
M T Shata
D-H Lee
A M Prince
G T Strickland
Cairo University · EGNew York Blood Center · USUniversity of Cincinnati Medical Center · USUniversity of Maryland, Baltimore · US

Funding

PROPHYLACTIC &THERPEUTIC DNA IMMUNIZATION AGAINST HCVR01AI047349 · NIAID · NEW YORK BLOOD CENTER · PI PRINCE, ALFRED M · 1999 to 2003
$2.0M
NIAID NIH HHS R01 AI047349NIAID NIH HHS R01 AI047349-05NIAID NIH HHS R01-AI47349Wellcome Trust
6 · The paper itself

Abstract

Patients coinfected with hepatitis C virus (HCV) and the trematode, Schistosoma mansoni, have an increased incidence of viral persistence and accelerated fibrosis. To investigate immunological mechanisms responsible for this more aggressive natural history of HCV, the core HCV-specific T-cell responses were analysed in 44 donated blood units rejected because they had antibodies to HCV (anti-HCV). Half also had anti-S. mansoni antibodies, evidence of past or active infection. HCV-specific ELISPOT responses were examined using pools of 180 overlapping 9-mer peptides with offsets of one covering the core of HCV genotype 4a. Comparison of T-cell responses in blood units positive for both anti-HCV and anti-Schistosoma antibodies with blood units positive only for anti-HCV antibodies showed a significant decrease in core-specific T-cell IFN-gamma (505+/- 46 vs. 803 +/- 66 ISC/10(6) cells, P < 0.001), IL-4 (2 +/- 108 vs. 641 +/- 131 ISC/10(6) cells, P < 0.001), and IL-10 (159 +/- 105 vs. 466 +/- 407 ISC/10(6) cells, P < 0.002) responses. In contrast, there was no significant difference in cell-mediated immune response (CMI) to PHA mitogen between these two groups. Therefore, we concluded T cells from persons with anti-Schistosoma have reduced IFN-gamma, IL-4, and IL-10 secreting HCV-specific T-cell responses. This may explain why Schistosoma coinfection increases persistence and severity of HCV infection.

Indexed as

AnimalsCytokinesHepacivirusHepatitis CHepatitis C AntibodiesHumansImmunity, CellularImmunosuppression TherapyLymphocyte ActivationPeptidesSchistosoma mansoniSchistosomiasis mansoniT-LymphocytesViral Core ProteinsCytokinesHepatitis C Antibodiesnucleocapsid protein, Hepatitis C virusPeptidesViral Core Proteins

Identifiers

PMID15987342
PMCPMC3906676
OpenAlexW2056707440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.